Expression profiling of core genes in NSCLC patients revealed significantly elevated expression of CCNA2, CDK1, and EGFR, whereas FOS, CCL2, and CAV1 exhibited reduced expression. This evidence concerns the gene CDK1 and non-small cell lung carcinoma.